Related references
Note: Only part of the references are listed.Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs
Tomoya Muto et al.
NATURE IMMUNOLOGY (2020)
Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes
Valentina Giudice et al.
CYTOKINE (2019)
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
David A. Sallman et al.
BLOOD (2019)
Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors: an updated patent review (2016-2018)
William T. McElroy
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Myelodysplastic syndrome-associated spliceosome gene mutations enhance innate immune signaling
Daniel A. Pollyea et al.
HAEMATOLOGICA (2019)
S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
Pinyang Cheng et al.
LEUKEMIA (2019)
Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome
Angel Y. F. Kam et al.
CLINICAL CANCER RESEARCH (2019)
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies
Molly A. Smith et al.
NATURE CELL BIOLOGY (2019)
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
Aref Al-Kali et al.
MAYO CLINIC PROCEEDINGS (2019)
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
Jiahao Chen et al.
NATURE MEDICINE (2019)
Management of myelodysplastic syndromes after failure of response to hypomethylating agents
Angela Gil-Perez et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS
Darlene A. Monlish et al.
BLOOD (2018)
Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines
Eva Villamon et al.
CANCER CELL INTERNATIONAL (2018)
Myelodysplastic syndromes current treatment algorithm 2018
David P. Steensma
BLOOD CANCER JOURNAL (2018)
ASC specks: a biomarker for myelodysplastic syndromes?
Dominik Wolf et al.
LANCET HAEMATOLOGY (2018)
Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study
Ashley A. Basiorka et al.
LANCET HAEMATOLOGY (2018)
Chronic immune response dysregulation in MDS pathogenesis
Laura Barreyro et al.
BLOOD (2018)
Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management
Guillermo Montalban-Bravo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Assembly and regulation of ASC specks
Florian Hoss et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia
Jing Fang et al.
NATURE IMMUNOLOGY (2017)
Clonal evolution in myelodysplastic syndromes
Pedro da Silva-Coelho et al.
NATURE COMMUNICATIONS (2017)
The genomic landscape of pediatric myelodysplastic syndromes
Jason R. Schwartz et al.
NATURE COMMUNICATIONS (2017)
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
Mia Eriksson et al.
BLOOD ADVANCES (2017)
Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness
Hitoshi Takizawa et al.
CELL STEM CELL (2017)
S100A9 induces differentiation of acute myeloid leukemia cells through TLR4
Malika Laouedj et al.
BLOOD (2017)
Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions
Ali N. Chamseddine et al.
CURRENT ONCOLOGY REPORTS (2016)
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
Astrid Olsnes Kittang et al.
ONCOIMMUNOLOGY (2016)
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Ashley A. Basiorka et al.
BLOOD (2016)
Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia
Noemi A. Zambetti et al.
CELL STEM CELL (2016)
GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
Lorenzo Sborgi et al.
EMBO JOURNAL (2016)
Apoptosis in human myelodysplastic syndrome CD34+cells is modulated by the upregulation of TLRs and histone H4 acetylation via a β-arrestin 1 dependent mechanism
Qing Zeng et al.
EXPERIMENTAL CELL RESEARCH (2016)
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Xing Liu et al.
NATURE (2016)
ASC filament formation serves as a signal amplification mechanism for inflammasomes
Mathias S. Dick et al.
NATURE COMMUNICATIONS (2016)
Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms
A. C. Herman et al.
BLOOD CANCER JOURNAL (2016)
Sepsis Induces Hematopoietic Stem Cell Exhaustion and Myelosuppression through Distinct Contributions of TRIF and MYD88
Huajia Zhang et al.
STEM CELL REPORTS (2016)
Unraveling the Pathogenesis of MDS: The NLRP3 inflammasome and Pyroptosis Drive the MDS Phenotype
David A. Sallman et al.
FRONTIERS IN ONCOLOGY (2016)
Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
Vijaya Raj Bhatt et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists
RuiKun Zhong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Deconstructing innate immune signaling in myelodysplastic syndromes
Melinda E. Varney et al.
EXPERIMENTAL HEMATOLOGY (2015)
Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling
Melinda E. Varney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
I. Ganan-Gomez et al.
LEUKEMIA (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
Regulation of Toll-like Receptor Signaling by the SF3a mRNA Splicing Complex
Brian P. O'Connor et al.
PLOS GENETICS (2015)
Inflammatory signaling regulates hematopoietic stem and progenitor cell emergence in vertebrates
Qiuping He et al.
BLOOD (2015)
The role of TLR8 signaling in acute myeloid leukemia differentiation
J. J. Ignatz-Hoover et al.
LEUKEMIA (2015)
Proinflammatory Signaling Regulates Hematopoietic Stem Cell Emergence
Raquel Espin-Palazon et al.
CELL (2014)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
Pediatric Myelodysplastic Syndromes: They Do Exist!
Taly Glaubach et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T. Haferlach et al.
LEUKEMIA (2014)
G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling
L. G. Schuettpelz et al.
LEUKEMIA (2014)
In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC
Maryam Nourizadeh et al.
TARGETED ONCOLOGY (2014)
Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production
Maria Velegraki et al.
HAEMATOLOGICA (2013)
Induction of myelodysplasia by myeloid-derived suppressor cells
Xianghong Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Toll-like receptor alterations in myelodysplastic syndrome
Y. Wei et al.
LEUKEMIA (2013)
Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes
Sophie Dimicoli et al.
PLOS ONE (2013)
S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-kappa B
Jean-Christophe Simard et al.
PLOS ONE (2013)
Limiting of the Innate Immune Response by SF3A-Dependent Control of MyD88 Alternative mRNA Splicing
Lesly De Arras et al.
PLOS GENETICS (2013)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Demand-adapted regulation of early hematopoiesis in infection and inflammation
Hitoshi Takizawa et al.
BLOOD (2012)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Inflammation-induced up-regulation of TLR2 expression in human endothelial cells is independent of differential methylation in the TLR2 promoter CpG island
Britta Diesel et al.
INNATE IMMUNITY (2012)
Differential Constitutive and Cytokine-Modulated Expression of Human Toll-like Receptors in Primary Neutrophils, Monocytes, and Macrophages
D. Shane O'Mahony et al.
International Journal of Medical Sciences (2012)
Synergistic effect of Toll-like receptor 4 and 7/8 agonists is necessary to generate potent blast-derived dendritic cells in Acute Myeloid Leukemia
Maryam Nourizadeh et al.
LEUKEMIA RESEARCH (2012)
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Timothy A. Graubert et al.
NATURE GENETICS (2012)
Direct Toll-Like Receptor-Mediated Stimulation of Hematopoietic Stem and Progenitor Cells Occurs In Vivo and Promotes Differentiation Toward Macrophages
Javier Megias et al.
STEM CELLS (2012)
The role of TLR2 in infect on and immunity
Laura Oliveira-Nascimento et al.
FRONTIERS IN IMMUNOLOGY (2012)
The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes
Azra Raza et al.
NATURE REVIEWS CANCER (2012)
Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes
Michael A. Schmid et al.
BLOOD (2011)
Chronic Exposure to a TLR Ligand Injures Hematopoietic Stem Cells
Brandt L. Esplin et al.
JOURNAL OF IMMUNOLOGY (2011)
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells
Evelien L. J. M. Smits et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia
Nobuo Kuninaka et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Functional diversity of stem and progenitor cells with B-lymphopoietic potential
Michiko Ichii et al.
IMMUNOLOGICAL REVIEWS (2010)
The TAK1-TRAF6 signalling pathway
Marene Landstrom
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype
Daniel T. Starczynowski et al.
NATURE MEDICINE (2010)
DAMPening Inflammation by Modulating TLR Signalling
A. M. Piccinini et al.
MEDIATORS OF INFLAMMATION (2010)
Toll-like Receptors (TLRs) are expressed by myeloid leukaemia cell lines, but fail to trigger differentiation in response to the respective TLR ligands
Masashi Okamoto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4
Precious G. Motshwene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Pyroptosis: host cell death and inflammation
Tessa Bergsbaken et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection
Robert S. Welner et al.
BLOOD (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands
Nicole Fitzner et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alpha
Manfred Lehner et al.
LEUKEMIA RESEARCH (2007)
Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome
Daniella B. Kerbauy et al.
EXPERIMENTAL HEMATOLOGY (2007)
Mrp8 and Mrp14 are endogenous activators of Toll- like receptor 4, promoting lethal, endotoxin-induced shock
Thomas Vogl et al.
NATURE MEDICINE (2007)
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation
T. Fernandes-Alnemri et al.
CELL DEATH AND DIFFERENTIATION (2007)
Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells
E. L. J. M. Smits et al.
LEUKEMIA (2007)
Toll-like receptors in the brain and their potential roles in neuropathology
Peter J. Crack et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes
Christos I. Maratheftis et al.
CLINICAL CANCER RESEARCH (2007)
Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment
Yoshinori Nagai et al.
IMMUNITY (2006)
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia
YW Lin et al.
BLOOD (2005)
Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-Binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the toll-like receptor signaling
S Sato et al.
JOURNAL OF IMMUNOLOGY (2003)
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
K Hoebe et al.
NATURE (2003)
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway
M Yamamoto et al.
SCIENCE (2003)
IKKε and TBK1 are essential components of the IRF3 signaling pathway
KA Fitzgerald et al.
NATURE IMMUNOLOGY (2003)
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction
H Oshiumi et al.
NATURE IMMUNOLOGY (2003)
Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4
K Burns et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Cutting edge:: A novel toll/IL-1 receptor Domain containing adapter that preferentially activates the IFN-β promoter in the toll-like receptor signaling
M Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2002)
More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia
YO Huh et al.
LEUKEMIA (2002)
Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins
O Takeuchi et al.
JOURNAL OF IMMUNOLOGY (2002)
Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines
KA Zarember et al.
JOURNAL OF IMMUNOLOGY (2002)
Discrimination of bacterial lipoproteins by Toll-like receptor 6
O Takeuchi et al.
INTERNATIONAL IMMUNOLOGY (2001)
Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells
TH Chuang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS
JE Parker et al.
BLOOD (2000)
Toll-like receptors in the induction of the innate immune response
A Aderem et al.
NATURE (2000)
Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates
V Shetty et al.
BLOOD (2000)
Share Paper
